ArticleTransplantation direct2026

Favorable Adherence and Tolerability of Letermovir Versus Valganciclovir for Cytomegalovirus Prophylaxis in Kidney Transplant Recipients Aged 65 y or Older: Findings From a Randomized, Phase 3 Trial.

Suphamai Bunnapradist et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.